Writing in the Wall Street Journal, Goodman Institute Senior Fellow Lawrence Kotlikoff and Harvard epidemiologist Michael Mina say the new point of care test developed by Abbott Labs is the right test at the right time.
Here is the disappointment. To conform with government regulations, this test has to be administered in the presence of a medical professional (such as a nurse). That means its value will be limited to schools, large companies, hospitals, etc. It won’t be useful for people who most need to be tested. We don’t insist on having a nurse present when a woman conducts her own pregnancy test. How is a Covid test any different?
What we really need are 150 million tests a day. In the home. MORE